Prognostic Nomogram for Predicting Survival in Asian Patients With Small‐Cell Lung Cancer: A Comprehensive Population‐Based Study and External Verification
The Clinical Respiratory Journal · 2024
DOI: 10.1111/crj.70021 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2024. Verfasst von Yuanli Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Clinical Research Center for Respiratory Diseases of Zhejiang Province, Department of Respiratory Disease, Thoracic Disease Center, The First Aff…. Hauptthemen laut MEDLINE: Nomograms, Small Cell Lung Carcinoma, Lung Neoplasms, SEER Program. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medicine Health Technology Plan of Zhejiang Province, China, Natural Science Foundation of Zhejiang Province, General Project of Education Department of Zhejiang Province.
Abstract (Originalsprache)
Background
The incidence of small cell lung cancer (SCLC) among Asian patients is on the rise. Nevertheless, there remains a deficiency in precise prognostic models tailored to the specific needs of this patient population. It is imperative to develop a novel nomogram aimed at forecasting the prognosis of Asian SCLC patients.
Methods
The SEER database supplied data on 661 Asian SCLC patients, who were then divided into training and internal validation sets through a random selection process. In addition, we identified 212 patients from a Chinese medical institution for the purpose of creating an external validation cohort. To forecast survival, we employed both univariate and multivariate analyses. The performance of our nomogram was assessed through calibration plots, the concordance index (C‐index), and decision curve analysis (DCA).
Results
Five independent prognostic factors were determined and integrated into the nomogram. C‐index values for the training and internal validation cohorts were 0.774 (95% confidence interval [CI] = 0.751–0.797) and 0.731 (95%CI = 0.690–0.772), respectively. In the external validation cohort, the C‐index is 0.712 (95% CI = 0.655–0.7692). Calibration curves demonstrated highly accurate predictions. When compared to the AJCC staging system, our model exhibited improved net benefits in DCA. Furthermore, the risk stratification system effectively differentiated patients with varying survival risks.
Conclusion
We have created a novel nomogram for predicting the survival of Asian patients with SCLC. This nomogram has been subjected to external validation and has shown its superiority over the conventional TNM staging system. It offers a more precise and reliable means of forecasting the prognosis of Asian SCLC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Clinical Research Center for Respiratory Diseases of Zhejiang Province, Department of Respiratory Disease, Thoracic Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Ch…
ORCID-Profile: Yuanli Xia
Förderung
- Medicine Health Technology Plan of Zhejiang Province, China
- Natural Science Foundation of Zhejiang Province
- General Project of Education Department of Zhejiang Province
- Zhejiang Provincial Clinical Research Center for Respiratory Disease
Zitieren
APA
Xia, Y., Qu, J., Wang, Y., Zhu, Y., Zhou, J., & Zhou, J. (2024). Prognostic Nomogram for Predicting Survival in Asian Patients With Small‐Cell Lung Cancer: A Comprehensive Population‐Based Study and External Verification. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.70021
Vancouver
Xia Y, Qu J, Wang Y, Zhu Y, Zhou J, Zhou J. Prognostic Nomogram for Predicting Survival in Asian Patients With Small‐Cell Lung Cancer: A Comprehensive Population‐Based Study and External Verification. The Clinical Respiratory Journal. 2024. doi:10.1111/crj.70021
BibTeX
@article{Xia2024,
author = {Xia, Yuanli and Qu, Jingjing and Wang, Yufang and Zhu, Yanping and Zhou, Jianying and Zhou, Jianya},
title = {Prognostic Nomogram for Predicting Survival in Asian Patients With Small‐Cell Lung Cancer: A Comprehensive Population‐Based Study and External Verification},
journal = {The Clinical Respiratory Journal},
year = {2024},
doi = {10.1111/crj.70021}
}
EUVIMED